- Home
- HCI vs BLDEW Comparison
HCI vs BLDEW Comparison
Compare HCI & BLDEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCI
- BLDEW
- Stock Information
- Founded
- HCI 2006
- BLDEW 2014
- Country
- HCI United States
- BLDEW United States
- Employees
- HCI N/A
- BLDEW 281
- Industry
- HCI Property-Casualty Insurers
- BLDEW Transportation Services
- Sector
- HCI Finance
- BLDEW Consumer Discretionary
- Exchange
- HCI Nasdaq
- BLDEW Nasdaq
- Market Cap
- HCI N/A
- BLDEW N/A
- IPO Year
- HCI N/A
- BLDEW N/A
- Fundamental
- Price
- HCI $167.13
- BLDEW $0.19
- Analyst Decision
- HCI Buy
- BLDEW
- Analyst Count
- HCI 4
- BLDEW 0
- Target Price
- HCI $156.25
- BLDEW N/A
- AVG Volume (30 Days)
- HCI 100.4K
- BLDEW 51.0K
- Earning Date
- HCI 05-08-2025
- BLDEW 03-13-2025
- Dividend Yield
- HCI 0.96%
- BLDEW N/A
- EPS Growth
- HCI 4.59
- BLDEW N/A
- EPS
- HCI 10.52
- BLDEW N/A
- Revenue
- HCI $759,870,000.00
- BLDEW $241,814,000.00
- Revenue This Year
- HCI $18.55
- BLDEW N/A
- Revenue Next Year
- HCI $2.12
- BLDEW N/A
- P/E Ratio
- HCI $15.92
- BLDEW N/A
- Revenue Growth
- HCI 20.95
- BLDEW 12.04
- 52 Week Low
- HCI $83.65
- BLDEW $0.30
- 52 Week High
- HCI $151.88
- BLDEW $0.36
- Technical
- Relative Strength Index (RSI)
- HCI 76.92
- BLDEW N/A
- Support Level
- HCI $142.47
- BLDEW N/A
- Resistance Level
- HCI $149.86
- BLDEW N/A
- Average True Range (ATR)
- HCI 5.56
- BLDEW 0.00
- MACD
- HCI 1.56
- BLDEW 0.00
- Stochastic Oscillator
- HCI 75.55
- BLDEW 0.00
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.